Expert tips for curbing bad breath Penn In the News The New York Times Expert tips for curbing bad breath Mark Wolff of the School of Dental Medicine explains how to self-test for bad breath and how bacteria and gum disease can contribute to its presence. Twitter gives conservative news greater visibility than liberal content A Black Lives Matter rally in June, 2020, at Brooklyn's Grand Army Plaza in New York. (Image: AP Photo/Kathy Willen, File) Twitter gives conservative news greater visibility than liberal content This bias held even in the context of a social justice movement with left-leaning goals, according to research from Sandra González-Bailón of the Annenberg School for Communication and colleagues. Do vaccine lotteries work? Do vaccine lotteries work? Wharton’s Katy Milkman shares the lessons learned from last year’s Philly Vax Sweepstakes, a Penn-funded project designed to evaluate ways of increasing COVID-19 vaccinations in the city. Teen drivers often unsafe on the road with speeding and handheld cellphone use Penn In the News Science Daily Teen drivers often unsafe on the road with speeding and handheld cellphone use A study by Catherine McDonald of the School of Nursing finds that many teens are prone to risky behaviors while driving, particularly handheld cellphone use and speeding. Researching depression in low-income women Researching depression in low-income women The importance of addressing depression among low-income women in multiple contexts is a theme of recent research by April Ivey, Jacqueline Corcoran, and others at Penn’s School of Social Policy & Practice. New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Penn In the News WHYY (Philadelphia) New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Jason Karlawish of the Perelman School of Medicine says that the results for new Alzheimer’s drug lecanemab look promising, complimenting the representative diversity of clinical trials. How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process Penn In the News STAT News How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA. Dogs can smell your stress, study finds Penn In the News Salon.com Dogs can smell your stress, study finds James A. Serpell of the School of Veterinary Medicine discusses the potential value of a United Kingdom study suggesting that dogs can smell stress. Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
Twitter gives conservative news greater visibility than liberal content A Black Lives Matter rally in June, 2020, at Brooklyn's Grand Army Plaza in New York. (Image: AP Photo/Kathy Willen, File) Twitter gives conservative news greater visibility than liberal content This bias held even in the context of a social justice movement with left-leaning goals, according to research from Sandra González-Bailón of the Annenberg School for Communication and colleagues.
Do vaccine lotteries work? Do vaccine lotteries work? Wharton’s Katy Milkman shares the lessons learned from last year’s Philly Vax Sweepstakes, a Penn-funded project designed to evaluate ways of increasing COVID-19 vaccinations in the city.
Teen drivers often unsafe on the road with speeding and handheld cellphone use Penn In the News Science Daily Teen drivers often unsafe on the road with speeding and handheld cellphone use A study by Catherine McDonald of the School of Nursing finds that many teens are prone to risky behaviors while driving, particularly handheld cellphone use and speeding. Researching depression in low-income women Researching depression in low-income women The importance of addressing depression among low-income women in multiple contexts is a theme of recent research by April Ivey, Jacqueline Corcoran, and others at Penn’s School of Social Policy & Practice. New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Penn In the News WHYY (Philadelphia) New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Jason Karlawish of the Perelman School of Medicine says that the results for new Alzheimer’s drug lecanemab look promising, complimenting the representative diversity of clinical trials. How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process Penn In the News STAT News How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA. Dogs can smell your stress, study finds Penn In the News Salon.com Dogs can smell your stress, study finds James A. Serpell of the School of Veterinary Medicine discusses the potential value of a United Kingdom study suggesting that dogs can smell stress. Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
Researching depression in low-income women Researching depression in low-income women The importance of addressing depression among low-income women in multiple contexts is a theme of recent research by April Ivey, Jacqueline Corcoran, and others at Penn’s School of Social Policy & Practice.
New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Penn In the News WHYY (Philadelphia) New potential drug treatment for Alzheimer’s disease has Pa. patients, advocates, and doctors hopeful Jason Karlawish of the Perelman School of Medicine says that the results for new Alzheimer’s drug lecanemab look promising, complimenting the representative diversity of clinical trials. How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process Penn In the News STAT News How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA. Dogs can smell your stress, study finds Penn In the News Salon.com Dogs can smell your stress, study finds James A. Serpell of the School of Veterinary Medicine discusses the potential value of a United Kingdom study suggesting that dogs can smell stress. Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process Penn In the News STAT News How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process In an op-ed, Jason Karlawish of the Perelman School of Medicine outlines the reliable process required to properly evaluate the effects of lecanemab, a new Alzheimer’s drug already approved by the FDA. Dogs can smell your stress, study finds Penn In the News Salon.com Dogs can smell your stress, study finds James A. Serpell of the School of Veterinary Medicine discusses the potential value of a United Kingdom study suggesting that dogs can smell stress. Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
Dogs can smell your stress, study finds Penn In the News Salon.com Dogs can smell your stress, study finds James A. Serpell of the School of Veterinary Medicine discusses the potential value of a United Kingdom study suggesting that dogs can smell stress. Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
Biogen’s next Alzheimer drug feeds push for FDA approval revamp Penn In the News Bloomberg Biogen’s next Alzheimer drug feeds push for FDA approval revamp Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway. Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos. Load More
Generic heart pill shows early promise for alcohol use disorder Penn In the News Everyday Health Generic heart pill shows early promise for alcohol use disorder Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos.